Parabilis Medicines
$145.0M
Funding date
Valuation / Funding
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| January 8, 2026 | Later Stage VC (Series F) | $305.0M | N/A | - |
| January 23, 2025 | Later Stage VC (Series E) | $145.0M | N/A | - |
| November 17, 2022 | Later Stage VC (Series D) | $178.0M | N/A | - |
Current Valuation Metrics
Parabilis Medicines is currently valued at $400.0M as of January 23, 2025. The company has raised a total of $507.0M in funding across 3 funding rounds.
Capital Efficiency
With a capital efficiency ratio of 0.79x, Parabilis Medicines has achieved a valuation that is 0.79 times the total capital raised.
What is Parabilis Medicines Worth in 2026?
Parabilis Medicines is a leading private company in the Drug Discovery sector. Track Parabilis Medicines's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Parabilis Medicines Valuation is Determined
Private company valuations like Parabilis Medicines's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.